Compare IRWD & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | VREX |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.7M | 580.6M |
| IPO Year | 2009 | 2016 |
| Metric | IRWD | VREX |
|---|---|---|
| Price | $4.44 | $11.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.67 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 1.8M | 202.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1400.00 | N/A |
| EPS | ★ 0.15 | 0.05 |
| Revenue | $298,276,000.00 | ★ $811,000,000.00 |
| Revenue This Year | $57.95 | $5.35 |
| Revenue Next Year | $4.39 | $3.88 |
| P/E Ratio | ★ $28.87 | $232.40 |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $0.55 | $6.76 |
| 52 Week High | $5.78 | $14.57 |
| Indicator | IRWD | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 67.36 | 61.43 |
| Support Level | $3.07 | $11.43 |
| Resistance Level | $5.67 | $12.61 |
| Average True Range (ATR) | 0.23 | 0.35 |
| MACD | 0.14 | 0.22 |
| Stochastic Oscillator | 95.52 | 89.06 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.